United Therapeutics Corp. (UTHR)
493.98
+5.47
(+1.12%)
USD |
NASDAQ |
Dec 12, 16:00
493.98
0.00 (0.00%)
After-Hours: 16:11
United Therapeutics Research and Development Expense (Quarterly): 127.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Liquidia Corp. | 9.07M |
| Amgen, Inc. | 1.90B |
| Insmed, Inc. | 186.42M |
| Corcept Therapeutics, Inc. | 68.85M |
| Catalyst Pharmaceuticals, Inc. | 2.657M |